HLA Class II Alleles DRB1*11:01 and DBQ1*03:01 Unmask Immunogenic Susceptibility to Anti-Nivolumab Antibodies in Combination with Ipilimumab

by Elena Iemma | May 21, 2026

Immunogenicity risk assessment of peptide-related impurities identified in generic teriparatide products

by Elena Iemma | Dec 8, 2025

T-cell responses to highly conserved SARS-CoV-2 epitopes in Hispanic Americans receiving an mRNA COVID-19 vaccine

by Elena Iemma | May 28, 2025

In silico methods for immunogenicity risk assessment and human homology screening for therapeutic antibodies

by Elena Iemma | Apr 1, 2024

A SARS-CoV-2 NSP7 homolog of a Treg epitope suppresses CD4+ and CD8+ T cell memory responses

by Elena Iemma | Nov 27, 2023